Globus Medical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Globus Medical and other ETFs, options, and stocks.

About GMED

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. It engages in developing products that promote healing in patients with musculoskeletal disorders. 

CEO
Keith W. Pfeil
CEOKeith W. Pfeil
Employees
6,000
Employees6,000
Headquarters
Audubon, Pennsylvania
HeadquartersAudubon, Pennsylvania
Founded
2003
Founded2003
Employees
6,000
Employees6,000

GMED Key Statistics

Market cap
12.41B
Market cap12.41B
Price-Earnings ratio
23.43
Price-Earnings ratio23.43
Dividend yield
Dividend yield
Average volume
1.11M
Average volume1.11M
High today
$91.99
High today$91.99
Low today
$90.12
Low today$90.12
Open price
$91.48
Open price$91.48
Volume
170.07K
Volume170.07K
52 Week high
$101.40
52 Week high$101.40
52 Week low
$51.79
52 Week low$51.79

Stock Snapshot

The current Globus Medical(GMED) stock price is $91.92, with a market capitalization of 12.41B. The stock trades at a price-to-earnings (P/E) ratio of 23.43.

On 2026-04-09, Globus Medical(GMED) stock traded between a low of $90.12 and a high of $91.99. Shares are currently priced at $91.92, which is +2.0% above the low and -0.1% below the high.

Globus Medical(GMED) shares are trading with a volume of 170.07K, against a daily average of 1.11M.

In the last year, Globus Medical(GMED) shares hit a 52-week high of $101.40 and a 52-week low of $51.79.

In the last year, Globus Medical(GMED) shares hit a 52-week high of $101.40 and a 52-week low of $51.79.

GMED News

Simply Wall St 6d
Assessing Globus Medical Valuation After Recent Share Price Moves And Robotics Growth Narrative

Advertisement Setting the scene for Globus Medical Globus Medical (GMED) has been drawing fresh attention after recent share price moves, with the stock last...

Assessing Globus Medical Valuation After Recent Share Price Moves And Robotics Growth Narrative

Analyst ratings

69%

of 16 ratings
Buy
68.8%
Hold
31.3%
Sell
0%

People also own

Based on the portfolios of people who own GMED. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.